BTK-IN-48 is a BTK inhibitor with an IC50 of 1.14 µM. BTK-IN-48 inhibits recombinant BTK and c-Src, and exerts moderate inhibitory effects on LCK, BMX/ETK, FLT3 and PIM1. BTK-IN-48 can be used in the research of B-cell malignancies and autoimmune diseases[1].
Molecular Weight:
333.34
CAS Number:
[3114078-55-3]
Formula:
C19H15N3O3
Target:
BMX Kinase,Btk,FLT3,Pim,Src
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted